Quality by Design (QbD) initiatives have become a new priority in pharmaceutical manufacturing as companies are caught between heightened regulatory scrutiny and the demand for greater operational efficiency. The key principle of QbD is to build more robust and tighter process capabilities with reduced variation—to build the quality into the product and the processes in order to reduce reject rates.
In 2013, Capsugel launched the first stage in a paradigm shift for quality in capsules with the introduction of Coni-Snap Sigma Series capsules. Sigma Series capsules is the designation given all capsules manufactured to sigma quality standards—with quality measured to a parts per million (PPM) level instead of the industry standard Acceptable Quality Levels (AQL) percentages. All Capsugel capsules—printed and unprinted—will be the product of this unparalleled increase in quality standards as this implementation schedule rolls out across all products and around the world through 2014 and 2015.
All along on the supply chain, Coni-Snap Sigma Series is designed to operate with greater assurance of quality, safety and regulatory compliance